Hartford Healthcare HLS Fund Class IB (HBGHX) - Health fund with $350.11 Million in assets. The fund allocates 45.65% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 13.70% of total assets. This is followed by UnitedHealth Group Inc (5.36%) and Merck Co Inc (5.50%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 13.70% | - | - |
| UnitedHealth Group Inc | 5.36% | - | - |
| Merck Co Inc | 5.50% | - | - |
| Danaher Corp | 3.11% | - | - |
| Boston Scientific Corp | 3.42% | - | - |
| Thermo Fisher Scientific Inc | 2.76% | - | - |
| Vertex Pharmaceuticals Inc | 2.77% | - | - |
| Stryker Corp | 2.43% | - | - |
| HCA Healthcare Inc | 2.40% | - | - |
| AbbVie Inc | 4.20% | - | - |
| Intuitive Surgical Inc | 3.96% | - | - |
| Johnson Johnson | 4.77% | - | - |
| Cencora Inc | 2.76% | - | - |
| Edwards Lifesciences Corp | 2.98% | - | - |